XML 14 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Unaudited Condensed Consolidated Statements of Changes In Equity - USD ($)
Common stock
Additional Paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total
Balance at Dec. 31, 2023 $ 38,491 $ 95,726,623 $ (34,961,476) $ 60,803,638
Balance (in Shares) at Dec. 31, 2023 1,399,676        
Correction of par value misstatement [1] $ (31,493) 31,493
Effect of rounding fractional shares into whole shares upon reverse stock split $ 377 (377)
Effect of rounding fractional shares into whole shares upon reverse stock split (in Shares) 75,458        
Private placement $ 6,998 15,459,407 15,466,405
Private placement (in Shares) 1,399,675        
Issuance of common stock warrants (11,158,348) (11,158,348)
Cashless exercise of common stock warrants $ 6,053 3,363,313 3,369,366
Cashless exercise of common stock warrants (in Shares) 1,210,572        
Net profit (loss) 6,286,001 6,286,001
Balance at Jun. 30, 2024 $ 20,426 103,422,111 (28,675,475) 74,767,062
Balance (in Shares) at Jun. 30, 2024 4,085,381        
Balance at Dec. 31, 2024 $ 25,326 109,539,147 (28,664,962) $ 80,899,511
Balance (in Shares) at Dec. 31, 2024 5,065,150       5,065,150
Net profit (loss) (810,938) $ (810,938)
Balance at Jun. 30, 2025 $ 25,326 $ 109,539,147 $ (29,475,900) $ 80,088,573
Balance (in Shares) at Jun. 30, 2025 5,065,150       5,065,150
[1] Reclassification between common stock and additional paid-in capital has been prospectively corrected in the current period due to the application of incorrect par value of common stock during the year ended December 31, 2023.